Literature DB >> 1387814

Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis.

J Miyauchi1, Y Ito, T Kawano, Y Tsunematsu, K Shimizu.   

Abstract

Transient myeloproliferative disorder (TMD), an acute leukemia-like disorder in neonates with Down's syndrome, is characterized by spontaneous regression of abnormal blast growth. Because proliferating blasts frequently express phenotypes of megakaryocytic lineage and, as a result, this disorder resembles acute megakaryoblastic leukemia (AMKL), it would be of interest to determine whether myelofibrosis, a common complication of AMKL, is also present in TMD. Pathologic observations of four autopsy cases of TMD showed that myelofibrosis was not present in any of them, whereas intralobular diffuse liver fibrosis was present in all of them. Laboratory data of four additional cases showed hepatic dysfunction in all of them, suggesting a close association between hepatic lesions and TMD. From these results, we propose a hypothesis that the abnormal blasts with megakaryocytic properties in TMD originate from the fetal liver and cause liver fibrosis, as AMKL cells are thought to cause myelofibrosis by producing collagen-stimulating cytokines in the bone marrow. This hypothesis also seems to explain some other unique aspects of TMD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387814

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

2.  Hepatic failure, neonatal hemochromatosis and porto-pulmonary hypertension in a newborn with trisomy 21--a case report.

Authors:  Erin Neil; Josef Cortez; Aparna Joshi; Erawati V Bawle; Janet Poulik; Mark Zilberman; Mohammad F El-Baba; Beena G Sood
Journal:  Ital J Pediatr       Date:  2010-05-18       Impact factor: 2.638

3.  Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis.

Authors:  Myoung Ja Park; Manabu Sotomatsu; Kentaro Ohki; Kokoro Arai; Kenichi Maruyama; Tomio Kobayashi; Akira Nishi; Kiyoko Sameshima; Takeshi Takagi; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2013-12-14       Impact factor: 2.490

4.  Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.

Authors:  Yehudit Birger; Liat Goldberg; Timothy M Chlon; Benjamin Goldenson; Inna Muler; Ginette Schiby; Jasmin Jacob-Hirsch; Gideon Rechavi; John D Crispino; Shai Izraeli
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

Review 5.  Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome.

Authors:  N Yagihashi; K Watanabe; S Yagihashi
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

6.  De novo duplication of chromosome 16p in a female infant with signs of neonatal hemochromatosis.

Authors:  Eva Maria Christina Schwaibold; Iris Bartels; Helmut Küster; Michael Lorenz; Peter Burfeind; Ronja Adam; Barbara Zoll
Journal:  Mol Cytogenet       Date:  2014-01-23       Impact factor: 2.009

7.  Role of monocyte chemoattractant protein-1 in liver fibrosis with transient myeloproliferative disorder in down syndrome.

Authors:  Kenichiro Kobayashi; Takako Yoshioka; Jun Miyauchi; Atsuko Nakazawa; Nobutaka Kiyokawa; Toshiro Maihara; Ikuya Usami
Journal:  Hepatol Commun       Date:  2018-02-01

8.  Altered pro-inflammatory and anti-inflammatory plasma cytokines levels in children with Down's syndrome: A meta-analysis.

Authors:  Nitu Nigam; Prithvi K Singh; Neena Raizada; Balendra P Singh; Shalini Tripathi; Monica Agrawal; Harish Gupta; Sharad Singh; Ghizal Fatima; Sanjay K Nigam; Shailendra K Saxena
Journal:  J Family Med Prim Care       Date:  2021-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.